Literature DB >> 32394993

The development and initial tests for the psychometric properties of the COVID-19 Phobia Scale (C19P-S).

Ibrahim Arpaci1, Kasım Karataş2, Mustafa Baloğlu3.   

Abstract

Researchers predict that the negative effects of the novel coronavirus 2019 (COVID-19) pandemic will continue . These negative effects are not solely limited to psycho-pathological problems. Serious physiological, social, and economical difficulties due to COVID-19 have already been observed in various nations. In this study, we suggest a new type of specific phobia, which may be categorized under DSM-V 300.29. The current study developed a self-report instrument whose items address the specific phobia diagnosis criteria of the DSM-V and tested its initial psychometric properties. Results show that the scale has initial evidence of construct, convergent, and discriminant validity, and internal consistency reliability. The scale should be further tested; however, the COVID-19 Phobia Scale (C19P-S) items provide support for assessing the levels of phobia reactions among a wide range of age groups.
© 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C19P-S; COVID-19; Coronavirus; Phobia; Scale development

Year:  2020        PMID: 32394993      PMCID: PMC7211675          DOI: 10.1016/j.paid.2020.110108

Source DB:  PubMed          Journal:  Pers Individ Dif        ISSN: 0191-8869


Introduction

Coronavirus 2019 (COVID-19) entered the world's agenda as a deeply shaking worldwide pandemic. COVID-19 first appeared in Wuhan, China, on December 2019 and has quickly spread in other provinces of China and in many countries and continents (Hui et al., 2020). As the spread of the virus expanded geographically, increases in the number of deaths multiplied(Wu & McGoogan, 2020). On January 30th, 2020, the outbreak of a new strain of coronavirus was designated a “public health emergency of international concern” by the World Health Organization (WHO). On March 11th, it was declared as a “pandemic.” According to the data of the World Health Organization (WHO), COVID-19 spread to 187 countries, confirmed cases were 294.110; and confirmed deaths were recorded as 12.944 (WHO, 2020). The virus is still affecting large populations from various aspects including psychological, social, political, and economical. The number of death due to COVID-19 is still increasing and the virus is not yet fully controlled. During epidemics, people usually experience various psychological difficulties such as fear, panic, or phobia. It has been reported that similar epidemics such as H1N1, SARS, MERS, Ebola, and Zika have previously had serious negative effects and caused fear and anxiety disorders (e.g., Ibrahim, 2016; Kim & Song, 2017; Liu, Zhang, & Lu, 2005; Tausczik, Faasse, Pennebaker, & Petrie, 2012; Theresa, Christian, & Nnadi, 2014). Similarly, the frequent exposure to COVID-19 in written, visual, and social media increases the levels of anxiety and fear among the public. It is already reported that the COVID-19 pandemic is increasing the risk of mental disorders including schizophrenia, anxiety, depression, and acute stress disorder among both the healthcare personnel and the public (e.g., Hu, Su, Qiao, Zhu, & Zhou, 2020; Huang et al., 2020; Huang & Liu, 2020; Kang et al., 2020; Li et al., 2020; Liu, Yang, et al., 2020; Liu, Zhang, et al., 2020; Sun et al., 2020; Xiang et al., 2020). At the same time, researchers predict that the negative effects of the COVID-19 pandemic lead to increases in extreme fear of illness, anger, alcohol/tobacco abuse, divorce, and suicide (Dai, Hu, Xiong, Qiu, & Yuan, 2020).

Theoretical background

Phobias are special forms of anxiety disorders defined by a persistent and excessive fear of an object or a situation and are classified into three groups (APA, 2013): Social phobia, agoraphobia, and specific phobia. Five specific phobia types are listed in DSM-V: Natural-environment, animal, blood-injection-injury (fear of injections and transfusions, fear of blood, fear of injury, fear of medical care), situational, and others. Thus, we purpose “corona phobia” as a persistent and excessive fear of the novel coronavirus, which can be classified as a particular type of the DSM-V specific phobia. Research indicates that specific phobias are the most frequently observed psychiatric disorders worldwide (Bandelow & Michaelis, 2015; Wardenaar et al., 2017). According to the DSM-V criteria, the main characteristic of specific phobias is fear or anxiety limited by the phobia source. If the individual occasionally feels anxious when encountering a particular object or situation, s/he is not to be diagnosed with specific phobia. Additionally, the response must be different from the usual and temporary fears that are common in society. At the same time, the level of fear or anxiety must be intense. The level of fear may vary depending on the proximity to the object or the situation. However, individuals do not have to show an extreme and meaningless anxiety response in order to be diagnosed with specific phobia. Considering the situation and the environment, the individual's “disproportionate” fear and anxiety response is sufficient for diagnosis (APA, 2013). Specific phobias can trigger other anxiety disorders and are reported to comorbid with suicidal tendency, major depression, anxiety disorders, and physical, mental, or mood disorders (Ausín, Muñoz, Castellanos, & García, 2020; Corchs et al., 2006; Keyes, Deale, Foster, & Veale, 2020; Witthauer et al., 2016). Specific phobias may emerge depending on the temperamental, genetic, and physiological antecedents as well as the influence of the environmental conditions (APA, 2013). In this sense, major man-made catastrophes or natural disasters, such as the COVID-19 pandemic, can be the environmental trigger of phobic conditions. People develop disproportional cognitive, affective, or behavioral responses to the objects and situations that they associate with the COVID-19 pandemic and severe deteriorations may occur in the physiological and psychological functionalities. Accordingly, because the COVID-19 pandemic causes extreme fear, anxiety, and reactions, we purpose it as another type of “specific phobia.” The COVID-19 pandemic disrupts people's routines and therefore elicits anxiety and phobic reactions (Li et al., 2020; Duan & Zhu, 2020; Wang, Cheng, Yue, & McAleer, 2020; Xiao, 2020). On the other hand, it is often noted in anecdotal experiences that people are afraid of being infected with COVID-19. Previous studies show that natural disasters such as earthquakes or tsunamis; man-made catastrophes such as explosions, wars, or terrorism; or epidemics such as MERS, SARS, or Ebola lead to detrimental emotions such as phobia, anxiety, depression, hopelessness, and hostility in the short and long terms (Colorado, 2017; Hossain, Sultana, & Purohit, 2020; Qi, Yang, Tan, Wu, & Zhou, 2020; Steinberg & Daniel, 2020). Therefore, as expected, people have already started experiencing phobic reactions in the face of the COVID-19 pandemic. As the pandemic spreads quickly, COVID-19 is expected to lead to increased psycho-pathological problems due to the potential for easy transmission, lack of treatment, and higher levels of the virus-related deaths (Duan & Zhu, 2020; Gao et al., 2020; Rothan & Byrareddy, 2020). Serious negative physiological, social, and economical effects of the COVID-19 pandemic have already been observed in many nations. These negative effects are causing conditions including stress, depression, psycho-somatic, and psycho-social disorders. It is important to detect early sings of COVID-19 phobia in order to provide timely psychological support for individuals who display higher levels of it (Duan & Zhu, 2020; Qiu et al., 2020). However, because it is a relatively novel problem, no psychometrically sound assessment is found in the literature to assess the levels of phobia on COVID-19. As The American Psychiatric Association (APA) recommends the development of assessment tools adapted to DSM-V criteria for specific phobia disorders, Therefore, the current study aimed to develop a COVID-19 phobia scale (i.e., C19P-S), whose items correspond to the specific phobia (300.29, formerly known as simple phobia) diagnosis criteria of the DSM-V and whose psychometric properties are empirically supported. The C19P-S aims to both contribute to research and enrich future studies on coronavirus.

Method

Study 1

Sample

The sample of the first study, used for EFA, consisted of 1250 participants (765 women, 61.2%) with a mean age of 37.53 years (SD = 16.94, range = 17–89 years). Descriptive statistics calculated for this sample are reported in Table 1 .
Table 1

Descriptive statistics of the participants in Study 1.

FrequencyPercent
Marital statusMarried61949.5
Single58947.1
Other423.4
Educational attainmentUneducated665.3
Primary school26521.2
Secondary school836.6
High school1219.7
Undergraduate47738.2
Graduate17714.2
MSc/PhD423.4
Missing191.5
Socio-economic status (SES)High231.8
Middle-high26621.3
Middle71957.5
Middle-low18314.6
Low594.7
Chronic diseaseYes24419.5
No100680.5
Covid 19 diagnosisPositive50.4
Negative124599.6
Descriptive statistics of the participants in Study 1.

Procedure

Informed consents were obtained before data collection via Qualtrics. Instructions informed the participants about the study and asked to indicate their level of agreement on the statements from 1 “strongly disagree” to 5 “strongly agree” on a five-point Likert scale. Various exploratory and confirmatory steps were used in the item development phase. Relevant literature, including the existing specific phobia scales, and the DSM-V specific phobia criteria (300.29) were analyzed. DSM-V specific phobia diagnosis criterion states that persistent fear of coronavirus is excessive or unreasonable (A); exposure to coronavirus provokes immediate anxiety which may exhibit panic (B); person recognizes that the fear of coronavirus is excessive or unreasonable (C); coronavirus is avoided or else anxiety experienced (D); and people avoid, coronavirus but if they cannot then they feel anxious and such anxiety interferes significantly with their regular routine in various environments (E). A total of 102 initial items that correspond to the above-mentioned criteria were generated independently by the three researchers and rated independently by a panel of six specialists. Among the specialists, there were two psychologists, two psychiatrists, and two psychometricians. Specialists' ratings ranged from 1 to 10, where 1 indicated that the item did not assess corona phobia at all and should be omitted and 10 indicated that the item measured corona phobia adequately and should be retained. Items with similar content were combined or redundant items were eliminated. In additions, items which were rated lower than 0.80 (on average) by the panel were dropped from further investigations. Resulting 70 items were administered online and 1250 participants responded to these items. Collected data were subjected to exploratory factor analysis (EFA) and items whose loadings were <0.40 on any of the factors or loaded on more than a single factor were eliminated and the final 20 items were achieved. Finally, 2143 participants responded to 20 items (no one from the first study was included in study 2) and data were subjected to confirmatory factor analyses (CFA) for the evidence of construct validity. In addition, differences between coronavirus positive and negative groups were compared by multivariate analysis of variance (MANOVA) as the evidence of the scale's discriminant validity. As an evidence of reliability, internal consistency coefficients were computed.

Results

Face validity

A total of 102 items generated independently by the researchers were reviewed and rated independently by six specialists (i.e., 2 psychiatrists, 2 psychologists and 2 psychometricians) on a 10-point Likert scale. Specialists' average ratings ranged from 2.14 to 9.83 (mean = 9.16, SD = 1.28). Items rated higher than 0.80 on average were considered to have adequate face validity. There were 70 such items retained for exploratory factor analysis.

Exploratory factor analysis

We conducted EFA with maximum likelihood and varimax rotation to identify the factor structure of the C19P-S. EFA results showed that 50 items were either loaded on more than a single factor and the loading difference was smaller than 0.20 or failed to load on any single factor (loading < 0.40). After omitting such 50 items, the final run resulted in a four-factor solution, which accounted for 61.65% of the total variation. The four factors accounted for 16.97%, 16.30%, 16.19%, and 12.19% of the explained variance, respectively. Kaiser measure of sampling adequacy for EFA was 0.926 and Bartlett test of sphericity was significant, χ 2 (df=190) = 14,396.195, p < .001. All communalities were higher than the threshold of 0.40. Table 2 shows the rotated factor matrix.
Table 2

Rotated factor matrix.

FactorsItemsCommunalities1234
1. PsychologicalPsy10.6260.753
Psy20.6580.726
Psy30.3850.710
Psy40.7020.696
Psy50.6980.673
Psy60.6560.446
2. Psyho-somaticSom10.7490.866
Som20.6340.838
Som30.7760.750
Som40.7990.680
Som50.6360.638
3. EconomicEco10.6890.846
Eco20.8020.809
Eco30.7880.643
Eco40.6180.558
4. SocialSoc10.5470.786
Soc20.6510.727
Soc30.5640.515
Soc40.7370.505
Soc50.6870.488
Rotated factor matrix.

Internal consistency

Tests of normality suggested that kurtosis and skewness coefficients ranged within the threshold values of ±3, and therefore, the data was normally distributed (Table 3 ). Cronbach alpha coefficient of the 20 items was 0.925 and subscale reliabilities ranged from 0.851 to 0.903 (Table 3). Further, correlations among the factors were significant (p < .01) but not so high as to cause concern for multicollinearity (i.e., >0.90).
Table 3

Descriptive statistics and reliability.

Factors1.2.3.MeanS.D.Cronbach alphaSkewness (SE = 0.069)Kurtosis (SE = 0.138)
1. Psychological20.4585.5510.876−0.150−0.587
2. Psycho-somatic0.36810.0394.0120.8991.1761.881
3. Economic0.4730.4789.5693.7570.9030.7430.359
4. Social0.6250.4690.47615.3374.6520.8510.295−0.541

p < .01.

Descriptive statistics and reliability. p < .01.

Study 2

The sample of the second study, used for CFA, consisted of 2143 participants (1292 women, 60.3%) with a mean age of 39.66 years (SD = 16.87, range = 12–92 years). Descriptive statistics calculated for the second sample are reported in Table 4 .
Table 4

Descriptive statistics of the participants in Study 2.

FrequencyPercent
Marital statusMarried126358.9
Single81237.9
Other (divorced or widowed)683.2
Educational attainmentducation levelNo formal schooling1195.6
Primary school44020.5
Secondary school1999.3
High school26412.3
Undergraduate53124.8
Graduate43520.3
MSc/PhD1165.4
Missing391.8
Socio-economic status (SES)High321.5
Middle-high43220.2
Middle128860.1
Middle-low27212.7
Low1185.5
Chronic diseaseYes44820.9
No169479.0
COVID 19 diagnosisPositive140.5
Negative213399.5
International travelYes200.9
No212399.1
Contact with travelersYes1105.1
No203394.9
COVID-19 positive contactYes1918.9
No195291.1
Relative/friend dead from COVID-19Yes452.1
No209897.9
Descriptive statistics of the participants in Study 2.

Internal reliability

The subscales showed sufficient internal consistency (0.853 < α < 0.897), and Cronbach alpha for the overall scale was 0.926. Descriptive statistics, skewness, kurtosis, and reliability coefficients are reported in Table 5 .
Table 5

Descriptive statistics and reliability.

FactorsC19P-S itemsMeanSDSkewness (SE = 0.053)Kurtosis (SE = 0.106)α
PsychologicalPsy116.025.490.012−0.5670.876
Psy2
Psy3
Psy4
Psy5
Psy6
Psycho-somaticSom120.093.89−1.1781.9990.897
Som2
Som3
Som4
Som5
EconomicEco114.453.74−0.7420.2850.880
Eco2
Eco3
Eco4
SocialSoc114.854.61−0.288−0.5800.853
Soc2
Soc3
Soc4
Soc5
Descriptive statistics and reliability.

Convergent and discriminant validity

Convergent validity was investigated by composite reliability (CR) and average variance extracted (AVE) values. The results show that AVE and CR are higher than the thresholds of 0.50 and 0.70, respectively (Fornell & Larcker, 1981). Thus, convergent validity of the C19P-S evidenced. The results also show that each factor significantly correlated with the other factors (p < .01). Further, all square roots of the AVE values (reported in off-diagonal, Table 6 ) are higher than the cross-correlations; therefore, discriminant validity of the C19P-S is established. Table 6 shows inter-item correlations along with convergent and discriminant validity coefficients.
Table 6

Convergent and discriminant validity.

CRAVEEconomicPsychologicalPsycho-somaticSocial
Economic0.8750.6370.798
Psychological0.8780.5480.5490.740
Psycho-somatic0.8920.6230.6330.4240.790
Social0.8580.5490.5680.7290.5680.741

p < .01.

Convergent and discriminant validity. p < .01.

Construct validity

Confirmatory factor analysis (CFA) was conducted by SPSS-AMOS (v.23) to verify how well the four-factor structure fit the data. Multiple criteria including goodness of fit index (GFI), adjusted goodness of fit (AGFI), comparative fit index (CFI), normed fit index (NFI), incremental fit index (IFI), Tucker-Lewis fit index (TLI), and root mean squared error of approximation (RMSEA) were used to assess the fit of the model to data (Tabachnick & Fidell, 2007). The results evidenced adequate model fit: χ2 (df=125) = 446.930, χ2/df = 3.575, p < .001, GFI = 0.979, AGFI = 967, NFI = 0.981, IFI = 0.986, TLI = 0.981, CFI = 0.986, and RMSEA = 0.035 [90% confidence interval = 0.031 and 0.038]. Further, standardized item factor loadings ranged from 0.63 to 0.81. Fig. 1 shows the measurement model.
Fig. 1

The measurement model.

The measurement model.

Discriminant validity

One-way MANOVA was used to determine whether there was a significant difference in each factor between infected (COVID-19 positive) and randomly selected non-infected groups of subjects. Results showed that there was a statistically significant difference in corona phobia between infected (n = 14) and non-infected subjects (n = 20, randomly selected form n of 2133), F (4, 29) = 4.971, p = .004; Wilk's Λ = 0.593, partial η2 = 0.41, power = 0.93. One-way MANOVA was repeated to identify the differences between 14 infected (COVID-19 positive) and randomly selected 200 non-infected subjects (randomly selected form n of 2133 with replacement). Again, the results showed that there was a statistically significant difference in corona phobia between infected (n = 14) and non-infected subjects (n = 200), F (4, 209) = 10.85, p < .001; Wilk's Λ = 0.979, partial η2 = 0.021, power = 0.99. Finally, there was significant differences in the psychological factor, F (1) = 3.989, p < .05, partial η2 = 0.002, psycho-somatic factor, F (1) = 12.728, p < .001, partial η2 = 0.006, and social factor, F (1) = 8.327, p < .01, partial η2 = 0.004 between infected and non-infected subjects, where infected subjects scored higher than the non-infected.

Discussion

The present study purposed corona phobia as persistent and excessive fear of the novel coronavirus and developed and validated a 20-item, self-report instrument with a 5-point Likert-scale to assess the levels of corona phobia (COVID-19) among individuals of wide age range. All items in the scale are rated on a 5-point scale from “strongly disagree (1)” to “strongly agree (5)” (see Appendix A for C19P-S items and scoring). Findings show initial evidences that the C19P-S may be used to assess the severity of corona phobia. CFA suggests 20 items with four-factors: Psychological, Psycho-somatic, Economic, and Social. The four-factor structure found in sample 1 (n = 1250) subsequently confirmed in sample 2 (n = 2143). Additionally, results show that the scale demonstrate convergent and discriminant validity and internal consistency. Internal consistency coefficients for the sub-scales range from 0.85 to 0.90. Further, null hypothesis testing results show that the C19P-S differentiate the infected (COVID-19 positive) and non-infected subjects; however, the effect size of the differences are minimal (Ferguson, 2009) and should be interpreted with caution. In conclusion, findings provide initial evidence that the scale has promising reliability and validity properties. Nonetheless, the study has some limitations that should be addressed at this point. First, even though the samples were heterogonous, we assume that subjects in both samples are mostly non-diagnosed individuals in terms of any phobia. These measurements should also be tested with clinically diagnosed phobic cases that show the symptoms of clinical phobia. The instrument is named “corona phobia scale” and appropriately, its items should be further tested with clinical diagnostics information which may evidence the diagnostic accuracy of the items for classifying cases as clinically phobic. Finally, the base-rate of infected cases (14/2147 = 0.65%) did not allow us to conduct any method of classification analysis (i.e., a logistic regression or CART analysis). Future studies should replicate the results with culturally more diverse populations as well as clinically diagnosed patients. Classification analysis should be conducted to evidence classification power of the C19P-S.

CRediT authorship contribution statement

Ibrahim Arpaci: Conceptualization, Formal analysis, Methodology, Validation, Visualization, Writing - original draft, Writing - review & editing. Kasım Karataş: Investigation, Resources, Writing - original draft, Writing - review & editing. Mustafa Baloğlu: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing - original draft, Writing - review & editing.
Coronavirus 19 Phobia Scale (C19P-S) items
Psychological factors
1. The fear of coming down with coronavirus makes me very anxious.
2. I am extremely afraid that someone in my family might become infected by the coronavirus.
3. News about coronavirus-related deaths causes me great anxiety.
4. Uncertainties surrounding coronavirus cause me enormous anxiety.
5. The pace that coronavirus has spread causes me great panic.
6. I argue passionately (or want to argue) with people I consider to be behaving irresponsibly in the face of coronavirus.



Psycho-somatic factors
1. I experience serious stomachaches out of the fear of coronavirus.
2. I experience serious chest pain out of the fear of coronavirus.
3. I experience tremors due to the fear of coronavirus.
4. I experience sleep problems out of the fear of coronavirus.
5. Coronavirus makes me so tense that I find myself unable to do the thing I previously had no problem doing.



Economic factors
1. The possibility of food supply shortage due to the coronavirus pandemic causes me anxiety.
2. The possibility of shortages in cleaning supplies due to the cornavirus pandemic causes me anxiety.
3. I stock food with the fear of coronavirus.
4. After the coronavirus pandemic, I do not feel relaxed unless I constantly check on my supplies at home.



Social factors
1. After the coronavirus pandemic, I feel extremely anxious when I see people coughing.
2. After the coronavirus pandemic, I actively avoid people I see sneezing.
3. Following the coronavirus pandemic, I have noticed that I spend extensive periods of time cleaning my hands.
4. The fear of coming down with coronavirus seriously impedes my social relationships.
5. I am unable to curb my anxiety of catching coronavirus from others.
  23 in total

1.  Phobias, other psychiatric comorbidities and chronic migraine.

Authors:  Felipe Corchs; Juliane P P Mercante; Vera Z Guendler; Domingos S Vieira; Marcelo R Masruha; Frederico R Moreira; Marcio Bernik; Eliova Zukerman; Mario F P Peres
Journal:  Arq Neuropsiquiatr       Date:  2006-12       Impact factor: 1.420

2.  Time intensive cognitive behavioural therapy for a specific phobia of vomiting: A single case experimental design.

Authors:  Alexandra Keyes; Alicia Deale; Chloe Foster; David Veale
Journal:  J Behav Ther Exp Psychiatry       Date:  2019-10-23

3.  Public anxiety and information seeking following the H1N1 outbreak: blogs, newspaper articles, and Wikipedia visits.

Authors:  Yla Tausczik; Kate Faasse; James W Pennebaker; Keith J Petrie
Journal:  Health Commun       Date:  2011-08-09

4.  Prevalence and predictors of posttraumatic stress disorder and depression among adolescents over 1 year after the Jiuzhaigou earthquake.

Authors:  Junjun Qi; Xima Yang; Ruyue Tan; Xinchun Wu; Xiao Zhou
Journal:  J Affect Disord       Date:  2019-09-30       Impact factor: 4.839

5.  The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.

Authors:  David S Hui; Esam I Azhar; Tariq A Madani; Francine Ntoumi; Richard Kock; Osman Dar; Giuseppe Ippolito; Timothy D Mchugh; Ziad A Memish; Christian Drosten; Alimuddin Zumla; Eskild Petersen
Journal:  Int J Infect Dis       Date:  2020-01-14       Impact factor: 3.623

6.  Psychological interventions for people affected by the COVID-19 epidemic.

Authors:  Li Duan; Gang Zhu
Journal:  Lancet Psychiatry       Date:  2020-02-19       Impact factor: 27.083

7.  Online mental health services in China during the COVID-19 outbreak.

Authors:  Shuai Liu; Lulu Yang; Chenxi Zhang; Yu-Tao Xiang; Zhongchun Liu; Shaohua Hu; Bin Zhang
Journal:  Lancet Psychiatry       Date:  2020-02-19       Impact factor: 27.083

8.  Prevalence and Characterization of Specific Phobia Disorder in People over 65 Years Old in a Madrid Community Sample (Spain) and its Relationship to Quality of Life.

Authors:  Berta Ausín; Manuel Muñoz; Miguel Ángel Castellanos; Sara García
Journal:  Int J Environ Res Public Health       Date:  2020-03-15       Impact factor: 3.390

Review 9.  Progression of Mental Health Services during the COVID-19 Outbreak in China.

Authors:  Wen Li; Yuan Yang; Zi-Han Liu; Yan-Jie Zhao; Qinge Zhang; Ling Zhang; Teris Cheung; Yu-Tao Xiang
Journal:  Int J Biol Sci       Date:  2020-03-15       Impact factor: 6.580

10.  Mental health outcomes of quarantine and isolation for infection prevention: a systematic umbrella review of the global evidence.

Authors:  Md Mahbub Hossain; Abida Sultana; Neetu Purohit
Journal:  Epidemiol Health       Date:  2020-06-02
View more
  45 in total

1.  Cyberchondria, Covid-19 phobia, and well-being: a relational study on teachers.

Authors:  Neşe Karakaş; Çiğdem Tekin; Recep Bentli; Ekrem Demir
Journal:  Med Lav       Date:  2022-06-28       Impact factor: 2.244

2.  Validation of coronavirus-2019 phobia scale using preschool practitioners in urban and rural communities in Nigeria: Implication for educational sociologists.

Authors:  Gloria C Ugwu; Christian S Ugwuanyi; Eucharia N Aye; Celestine O Eze; Nkiru Christiana Ohia; Emmanuel C Okenyi; Theresa O Oforka; Charles A Oraelosi; Obiageli C Njoku; Victor S Ezema; Kelechi O Ifekoya; Chinyere Theresa Nwoga; Alexander Okondugba; Julia Amobi Onumonu; Rosemary Chinyere Ohaneme; Malachy A Ezeah
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

3.  Superstitious beliefs, locus of control, and feeling at risk in the face of Covid-19.

Authors:  Arvid Hoffmann; Daria Plotkina; Patrick Roger; Catherine D'Hondt
Journal:  Pers Individ Dif       Date:  2022-05-10

Review 4.  The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication.

Authors:  Qin Ning; Di Wu; Xiaojing Wang; Dong Xi; Tao Chen; Guang Chen; Hongwu Wang; Huiling Lu; Ming Wang; Lin Zhu; Junjian Hu; Tingting Liu; Ke Ma; Meifang Han; Xiaoping Luo
Journal:  Signal Transduct Target Ther       Date:  2022-02-23

5.  Insomnia during the COVID-19 pandemic: the role of depression and COVID-19-related risk factors.

Authors:  Kendra L Pizzonia; Brandon Koscinski; Julie A Suhr; Catherine Accorso; Darcey M Allan; Nicholas P Allan
Journal:  Cogn Behav Ther       Date:  2021-03-31

6.  Using Fear and Anxiety Related to COVID-19 to Predict Cyberchondria: Cross-sectional Survey Study.

Authors:  Xue Wu; Nabi Nazari; Mark D Griffiths
Journal:  J Med Internet Res       Date:  2021-06-09       Impact factor: 7.076

7.  Evaluation of COVID-19 phobia and the feeling of loneliness in the geriatric age group.

Authors:  Fatma G Cihan; Funda Gökgöz Durmaz
Journal:  Int J Clin Pract       Date:  2021-03-04       Impact factor: 3.149

8.  Mental Health Screening for COVID-19: a Proposed Cutoff Score for the Greek Version of the Fear of COVID-19 Scale (FCV-19S).

Authors:  V A Nikopoulou; V Holeva; Eleni Parlapani; P Karamouzi; P Voitsidis; G N Porfyri; A Blekas; K Papigkioti; S Patsiala; I Diakogiannis
Journal:  Int J Ment Health Addict       Date:  2020-11-10       Impact factor: 11.555

9.  The association between coronaphobia and attitude towards COVID-19 Vaccine: A sample in the east of Turkey.

Authors:  G B Turan; M Aksoy; Z Özer; C Demir
Journal:  Encephale       Date:  2021-06-12       Impact factor: 1.291

10.  Associations Between Resilience, Psychological Well-Being, Work-Related Stress and Covid-19 Fear in Forensic Healthcare Workers Using a Network Analysis.

Authors:  Stefan Bogaerts; Marianne van Woerkom; Yasemin Erbaş; Elien De Caluwé; Carlo Garofalo; Iris Frowijn; Ingeborg Jeandarme; Erik Masthoff; Marija Janković
Journal:  Front Psychiatry       Date:  2021-06-11       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.